Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more
Ildong Holdings Co Ltd - Asset Resilience Ratio
Ildong Holdings Co Ltd (000230) has an Asset Resilience Ratio of 1.57% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Ildong Holdings Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Ildong Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩12.78 Billion | 1.57% |
| Total Liquid Assets | ₩12.78 Billion | 1.57% |
Asset Resilience Insights
- Limited Liquidity: Ildong Holdings Co Ltd maintains only 1.57% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ildong Holdings Co Ltd Industry Peers by Asset Resilience Ratio
Compare Ildong Holdings Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp Preferred
KO:000105 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma
KO:000220 |
Drug Manufacturers - Specialty & Generic | 1.74% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
Annual Asset Resilience Ratio for Ildong Holdings Co Ltd (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Ildong Holdings Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.79% | ₩15.28 Billion | ₩854.70 Billion | -1.78pp |
| 2023-12-31 | 3.57% | ₩31.29 Billion | ₩877.00 Billion | -0.77pp |
| 2022-12-31 | 4.34% | ₩37.42 Billion | ₩862.55 Billion | +1.49pp |
| 2021-12-31 | 2.84% | ₩26.19 Billion | ₩920.76 Billion | +2.21pp |
| 2020-12-31 | 0.64% | ₩5.09 Billion | ₩799.40 Billion | +0.23pp |
| 2019-12-31 | 0.41% | ₩3.30 Billion | ₩805.63 Billion | -1.28pp |
| 2018-12-31 | 1.69% | ₩4.49 Billion | ₩265.47 Billion | +0.75pp |
| 2017-12-31 | 0.94% | ₩2.59 Billion | ₩274.84 Billion | -1.55pp |
| 2016-12-31 | 2.49% | ₩5.09 Billion | ₩204.09 Billion | +1.93pp |
| 2015-12-31 | 0.56% | ₩3.98 Billion | ₩705.64 Billion | +0.16pp |
| 2014-12-31 | 0.40% | ₩2.48 Billion | ₩620.35 Billion | -0.03pp |
| 2013-12-31 | 0.43% | ₩2.68 Billion | ₩628.21 Billion | -0.19pp |
| 2012-12-31 | 0.62% | ₩3.35 Billion | ₩541.71 Billion | -0.43pp |
| 2011-12-31 | 1.05% | ₩5.35 Billion | ₩511.65 Billion | -2.64pp |
| 2010-12-31 | 3.68% | ₩19.57 Billion | ₩531.23 Billion | +2.68pp |
| 2009-12-31 | 1.00% | ₩4.96 Billion | ₩495.53 Billion | -0.34pp |
| 2008-12-31 | 1.34% | ₩5.43 Billion | ₩404.79 Billion | +0.48pp |
| 2007-12-31 | 0.86% | ₩2.90 Billion | ₩336.03 Billion | -0.07pp |
| 2006-12-31 | 0.93% | ₩2.64 Billion | ₩283.77 Billion | +0.57pp |
| 2005-12-31 | 0.36% | ₩941.26 Million | ₩258.07 Billion | -0.09pp |
| 2004-12-31 | 0.45% | ₩1.05 Billion | ₩232.19 Billion | -0.30pp |
| 2003-12-31 | 0.75% | ₩1.65 Billion | ₩218.82 Billion | +0.20pp |
| 2002-12-31 | 0.56% | ₩1.09 Billion | ₩195.90 Billion | -0.14pp |
| 2001-12-31 | 0.70% | ₩1.27 Billion | ₩183.11 Billion | -0.21pp |
| 2000-12-31 | 0.91% | ₩1.70 Billion | ₩187.75 Billion | +0.78pp |
| 1999-12-31 | 0.12% | ₩234.02 Million | ₩188.81 Billion | -- |